SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: After Glaxo's genital herpes vaccine flop, check out Agenus

19 Jan 2015 10:46 AM <--
14 Dec 2012 03:21 PM

Return to After Glaxo's genital herpes vaccine flop, check out Agenus
 
Glaxo's (GSK) genital herpes vaccine flopped in a big recent trial, but next-gen vaccine developer Agenus (AGEN) is a long buy in this vaccine space. sandiegobiotechnology.com